Emtricitabine has one of the cleanest interaction profiles of any antiretroviral, which is a large part of why it is used so widely. There is one absolute rule and a short list of minor considerations.
Why does it interact so little?
Because it is cleared by the kidneys largely unchanged rather than being broken down by liver enzymes. Most significant drug interactions in HIV medicine involve the enzyme CYP3A4, and emtricitabine neither affects it nor is affected by it.
What is the absolute rule?
Never combine it with lamivudine. The two are closely related cytidine analogues that work by the same mechanism, offer no additional benefit together, and share the same resistance pathway. Taking both is duplication rather than intensification, and it happens occasionally when regimens are changed without the overlap being noticed.
How would that happen?
Usually through a combination tablet containing one and a separate tablet containing the other. If you are switching regimens, or have been prescribed something new by a service that does not know your full list, check that lamivudine and emtricitabine are not both present.
What affects its levels?
Anything that significantly reduces kidney function can raise them, since that is how it is cleared. In practice this means dose intervals are extended where function is reduced rather than that specific drugs cause a problem.
Does it interact with hormone therapy?
No, in either direction. Emtricitabine does not affect oestradiol or testosterone levels, and gender-affirming hormone therapy does not reduce its effectiveness. This applies to the tenofovir it is usually paired with as well, which together covers standard PrEP.
What about recreational drugs?
No pharmacological interaction. It does not block the enzyme that clears MDMA, methamphetamine, mephedrone or ketamine, unlike boosted HIV regimens containing ritonavir or cobicistat. The practical concerns with combinations containing it are dehydration and missed doses.
What about alcohol?
No direct interaction. The issues are missed doses and vomiting rather than anything pharmacological. If you vomit within an hour of a dose, take another.
What about supplements and antacids?
Fine. Emtricitabine is not bound by calcium, magnesium, iron or zinc, so no spacing is required. If your combination tablet contains an integrase inhibitor such as bictegravir or dolutegravir, that component does need spacing from those minerals.
What about anti-inflammatory painkillers?
Not an issue for emtricitabine itself. Regular use matters where the tablet also contains tenofovir disoproxil, since that adds to the kidney burden. Paracetamol has no interaction with anything in these combinations.
What about hepatitis C treatment?
Emtricitabine is not significantly affected. Some hepatitis C drugs do raise tenofovir levels, so where you are on a combination this is worth checking. Both teams should know what the other is prescribing.
How do you check a specific combination?
The University of Liverpool interaction checker covers antiretrovirals against prescription, over-the-counter and recreational drugs, and is what clinicians use themselves. A clinic pharmacist will check any combination without an appointment in a couple of minutes.
What about medicines from elsewhere?
Tell whoever prescribes what you take. Your sexual health record is held separately from your GP record, so nobody else automatically knows, and the responsibility for mentioning it sits with you.
Does it affect contraception?
No. Emtricitabine does not reduce the effectiveness of hormonal contraception in either direction. Where a combination tablet contains a booster, that component may, so the question is about the whole regimen.
What about things you would not think of as medicines?
Herbal remedies, particularly St John's wort, high-dose supplements, and products bought online all count. So do medicines prescribed by a dentist or a hospital team who cannot see your sexual health record. If you swallow it, inject it or apply it regularly, mention it.
What happens if an interaction is found?
Usually an adjustment rather than a crisis: a dose change, a different drug in the same class, or spacing the two apart. Genuine contraindications are a small minority, and they are almost always solvable by changing one of the two medicines.